MacroGenics Announces Lancet Oncology Publication of Margetuximab Data in Gastric Cancer

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/4/2026

1. CRWD
2. AVGO
3. VEEV
4. SPY
5. FIVE
6. NTSK
7. PLTR
8. VRTS
9. AI
10. MDT

Go back to MacroGenics Announces Lancet Oncology Publication of Margetuximab Data in Gastric Cancer
MACROGENICS (NASDAQ: MGNX) Delayed: 4.25 +0.05 (1.19%)
Previous Close $4.20    52 Week High $36.11 
Open $4.19    52 Week Low $14.84 
Day High $4.46    P/E 10.90 
Day Low $4.15    EPS $0.39 
Volume 520,461